114 related articles for article (PubMed ID: 22498341)
1. Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma.
Fragioudaki M; Tsirakis G; Pappa CA; Aristeidou I; Tsioutis C; Alegakis A; Kyriakou DS; Stathopoulos EN; Alexandrakis MG
Leuk Res; 2012 Aug; 36(8):1004-8. PubMed ID: 22498341
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of TNF superfamily molecules in multiple myeloma patients: correlation with biological and clinical features.
Lemancewicz D; Bolkun L; Jablonska E; Kulczynska A; Bolkun-Skornicka U; Kloczko J; Dzieciol J
Leuk Res; 2013 Sep; 37(9):1089-93. PubMed ID: 23768867
[TBL] [Abstract][Full Text] [Related]
3. B cell-activating factor: its clinical significance in multiple myeloma patients.
Fragioudaki M; Boula A; Tsirakis G; Psarakis F; Spanoudakis M; Papadakis IS; Pappa CA; Alexandrakis MG
Ann Hematol; 2012 Sep; 91(9):1413-8. PubMed ID: 22526370
[TBL] [Abstract][Full Text] [Related]
4. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
Kyrtsonis MC; Vassilakopoulos TP; Siakantaris MP; Kokoris SI; Gribabis DA; Dimopoulou MN; Angelopoulou MK; Pangalis GA
Eur J Haematol; 2004 Apr; 72(4):252-8. PubMed ID: 15089762
[TBL] [Abstract][Full Text] [Related]
5. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
6. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
7. BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma.
Bolkun L; Lemancewicz D; Jablonska E; Kulczynska A; Bolkun-Skornicka U; Kloczko J; Dzieciol J
Ann Hematol; 2014 Apr; 93(4):635-44. PubMed ID: 24141333
[TBL] [Abstract][Full Text] [Related]
8. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
9. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS
Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
Bhatti SS; Kumar L; Dinda AK; Dawar R
Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
[TBL] [Abstract][Full Text] [Related]
11. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
12. Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.
Molica S; Digiesi G; Battaglia C; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Gentile M; Morabito F; Ferrarini M
Eur J Haematol; 2010 Oct; 85(4):314-20. PubMed ID: 20546021
[TBL] [Abstract][Full Text] [Related]
13. Positive correlation between bone marrow mast cell density and ISS prognostic index in patients with multiple myeloma.
Pappa CA; Tsirakis G; Roussou P; Xekalou A; Goulidaki N; Konsolas I; Alexandrakis MG; Stathopoulos EN
Leuk Res; 2013 Dec; 37(12):1628-31. PubMed ID: 24183234
[TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis.
Bosello S; Youinou P; Daridon C; Tolusso B; Bendaoud B; Pietrapertosa D; Morelli A; Ferraccioli G
J Rheumatol; 2008 Jul; 35(7):1256-64. PubMed ID: 18528969
[TBL] [Abstract][Full Text] [Related]
17. High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment.
Urbańska-Ryś H; Robak T
Mediators Inflamm; 2003 Aug; 12(4):229-35. PubMed ID: 14514474
[TBL] [Abstract][Full Text] [Related]
18. Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma.
Kowalska M; Druzd-Sitek A; Fuksiewicz M; Kotowicz B; Chechlinska M; Syczewska M; Walewski J; Kaminska J
Clin Biochem; 2010 Apr; 43(6):604-8. PubMed ID: 20045402
[TBL] [Abstract][Full Text] [Related]
19. Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease.
Fabris M; Visentini D; De Re V; Picierno A; Maieron R; Cannizzaro R; Villalta D; Curcio F; De Vita S; Tonutti E
Scand J Gastroenterol; 2007 Dec; 42(12):1434-9. PubMed ID: 17852877
[TBL] [Abstract][Full Text] [Related]
20. Significance of Some Proliferation Markers and Some Prognostic Factors in Patients with Multiple Myeloma and their Impact on the Patients' Survival.
Abdelgawad IA; Radwan NH; Shafik RE; Shokralla HA
Asian Pac J Cancer Prev; 2016; 17(5):2389-94. PubMed ID: 27268602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
